Xiquan Chen – Trademark Portfolio
Entity Type: 01
Xiquan Chen owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as WALKV, PAUSEL, PLUCAR, TUYUSA, and VALGUS. Of these, 6 are registered. The portfolio spans 6 Nice Classification classes, led by Class 25 (Clothing) and Class 3 (Cosmetics & Cleaning). Headquartered in Jian'ou,Fujian.
No.81 Guoyuan
Yangze Village,Xiaoqiao Town
Jian'ou,Fujian 353100 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiquan Chen's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Precious metals and their alloys; jewellery, precious stones; horological instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Xiquan Chen have?
Xiquan Chen has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Xiquan Chen file in?
Xiquan Chen files trademarks across 6 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 3 (Cosmetics & Cleaning), Class 26 (Fancy Goods), Class 14 (Jewelry), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.
What are Xiquan Chen's most well-known trademarks?
Xiquan Chen's registered trademark portfolio includes well-known marks such as WALKV, PAUSEL, PLUCAR, TUYUSA, and VALGUS. These are among 6 currently registered trademarks in the portfolio.
What is Xiquan Chen's trademark registration success rate?
Xiquan Chen has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.